Literature DB >> 24242819

Immunobiology of TNFSF15 and TNFRSF25.

Taylor H Schreiber1, Eckhard R Podack.   

Abstract

TNFRSF25 is an understudied broad-acting T cell costimulator with high homology to TNFR1, however, the overall role of this receptor in T cell immunobiology is unclear. Ligation of TNFRSF25 by its monogamous ligand, TNFSF15 (TL1A), leads to recruitment of TNFR-associated factor 2 and TNFR-associated death domain in primary T cells with downstream activation of both NFκB as well as the PI3K/Akt axis. These signaling pathways are dependent upon coordinated engagement of the T cell receptor and interleukin-2 receptor and leads to the constitutive proliferation of CD4+FoxP3+ regulatory T cells (Treg) as a result of tonic exposure to self-antigen. Concurrent activation of CD4+ or CD8+ conventional T cell clones is dependent upon the availability of cognate foreign antigen. Here, we provide a review of both the literature and our work on this receptor and propose that the overall function of TL1A signaling to TNFRSF25 in T cells is to provide simultaneous costimulation of foreign-antigen-specific effector T cells and pre-existing Treg in order to focus the clonality of effector immunity to pathogen-derived antigens and reduce the risk of bystander inflammation toward self- or endogenous microbial antigens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242819     DOI: 10.1007/s12026-013-8465-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  51 in total

1.  Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.

Authors:  Keiko Yamazaki; Dermot McGovern; Jiannis Ragoussis; Marta Paolucci; Helen Butler; Derek Jewell; Lon Cardon; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Mark Lathrop; Yusuke Nakamura
Journal:  Hum Mol Genet       Date:  2005-10-12       Impact factor: 6.150

2.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

Authors:  Thi Sau Migone; Jun Zhang; Xia Luo; Li Zhuang; Cecil Chen; Bugen Hu; June S Hong; James W Perry; Su Fang Chen; Joe X H Zhou; Yun Hee Cho; Stephen Ullrich; Palanisamy Kanakaraj; Jeffrey Carrell; Ernest Boyd; Henrik S Olsen; Gang Hu; Laurie Pukac; Ding Liu; Jian Ni; Sunghee Kim; Reiner Gentz; Ping Feng; Paul A Moore; Steve M Ruben; Ping Wei
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

3.  Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Authors:  Tomasz J Slebioda; Tania F Rowley; John R Ferdinand; Jane E Willoughby; Sarah L Buchan; Vadim Y Taraban; Aymen Al-Shamkhani
Journal:  Eur J Immunol       Date:  2011-08-04       Impact factor: 5.532

4.  LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.

Authors:  G R Screaton; X N Xu; A L Olsen; A E Cowper; R Tan; A J McMichael; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

6.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

7.  X-ray crystal structure of TNF ligand family member TL1A at 2.1A.

Authors:  Tengchuan Jin; Feng Guo; Sunghee Kim; Andrew Howard; Yu-Zhu Zhang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-01       Impact factor: 3.575

8.  The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Authors:  F Meylan; Y-J Song; I Fuss; S Villarreal; E Kahle; I-J Malm; K Acharya; H L Ramos; L Lo; M M Mentink-Kane; T A Wynn; T-S Migone; W Strober; R M Siegel
Journal:  Mucosal Immunol       Date:  2010-10-27       Impact factor: 7.313

9.  Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.

Authors:  Taylor H Schreiber; Dietlinde Wolf; Maria Bodero; Eckhard Podack
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

10.  The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.

Authors:  Melanie Jane Bull; Anwen Siân Williams; Zarabeth Mecklenburgh; Claudia Jane Calder; Jason Peter Twohig; Carole Elford; Bronwen Alice James Evans; Tania F Rowley; Tomasz J Slebioda; Vadim Y Taraban; Aymen Al-Shamkhani; Eddie Chung Yern Wang
Journal:  J Exp Med       Date:  2008-09-29       Impact factor: 14.307

View more
  14 in total

1.  T Follicular Helper Cell-Dependent Clearance of a Persistent Virus Infection Requires T Cell Expression of the Histone Demethylase UTX.

Authors:  Kevin D Cook; Karl B Shpargel; Joshua Starmer; Fatima Whitfield-Larry; Bridget Conley; Denise E Allard; Julia E Rager; Rebecca C Fry; Marsha L Davenport; Terry Magnuson; Jason K Whitmire; Maureen A Su
Journal:  Immunity       Date:  2015-09-29       Impact factor: 31.745

2.  Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

Authors:  Shravan Madireddi; So-Young Eun; Amit K Mehta; Aruna Birta; Dirk M Zajonc; Toshiro Niki; Mitsuomi Hirashima; Eckhard R Podack; Taylor H Schreiber; Michael Croft
Journal:  J Immunol       Date:  2017-09-06       Impact factor: 5.422

Review 3.  Combination cancer immunotherapy and new immunomodulatory targets.

Authors:  Kathleen M Mahoney; Paul D Rennert; Gordon J Freeman
Journal:  Nat Rev Drug Discov       Date:  2015-08       Impact factor: 84.694

Review 4.  Type-2 innate lymphoid cells in asthma and allergy.

Authors:  Andrew N J McKenzie
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 5.  Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review).

Authors:  Yunhong Yu; Peng Jiang; Pan Sun; Na Su; Fangzhao Lin
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

Review 6.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

7.  A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.

Authors:  Li-Guo Jia; Giorgos Bamias; Kristen O Arseneau; Linda C Burkly; Eddy C Y Wang; Dennis Gruszka; Theresa T Pizarro; Fabio Cominelli
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

8.  TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis.

Authors:  M Facco; A Cabrelle; F Calabrese; A Teramo; F Cinetto; S Carraro; V Martini; F Calzetti; N Tamassia; M A Cassatella; G Semenzato; C Agostini
Journal:  Clin Mol Allergy       Date:  2015-08-03

9.  Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.

Authors:  Nichole R Klatt; Steven E Bosinger; Melicent Peck; Laura E Richert-Spuhler; Anke Heigele; Jillian P Gile; Nirav Patel; Jessica Taaffe; Boris Julg; David Camerini; Carlo Torti; Jeffrey N Martin; Steven G Deeks; Elizabeth Sinclair; Frederick M Hecht; Michael M Lederman; Mirko Paiardini; Frank Kirchhoff; Jason M Brenchley; Peter W Hunt; Guido Silvestri
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

10.  TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Authors:  Bruna Oriol-Tordera; Alex Olvera; Clara Duran-Castells; Anuska Llano; Beatriz Mothe; Marta Massanella; Judith Dalmau; Carmela Ganoza; Jorge Sanchez; Maria Luz Calle; Bonaventura Clotet; Javier Martinez-Picado; Eugènia Negredo; Julià Blanco; Dennis Hartigan-O'Connor; Christian Brander; Marta Ruiz-Riol
Journal:  J Immunol       Date:  2020-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.